LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Nitrosamines Analysis in Pharmaceuticals - Consumables workflow ordering guide

 

Similar PDF

Toggle
Application Note Pharmaceutical Small Molecules Simultaneous Determination of Eight Nitrosamine Impurities in Metformin Extended-Release Tablets Using the Agilent 6470 Triple Quadrupole LC/MS Detection of regulated genotoxic impurities from the drug manufacturing process Authors Chander Mani, Kartheek Srinivas Chidella, Saikat Banerjee,…
Key words
nitrosamine, nitrosaminenmpa, nmpandipa, ndipandpa, ndpandba, ndbaneipa, neipandea, ndeanmba, nmbaresponses, responsesndma, ndmaimpurities, impuritiesmetformin, metformindrug, drugeight, eightconcentration
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Key words
back, backndma, ndmaneipa, neipafda, fdandipa, ndipandea, ndeandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantdichloromethan
Application Note Determination of Nitrosamine Impurities Using the Agilent 6495D Triple Quadrupole LC/MS System Authors Abstract Lee Bertram and Linfeng Wu Agilent Technologies, Inc. Nitrosamine impurities are byproducts produced in trace amounts during the manufacture of pharmaceutical drugs. These impurities…
Key words
fragile, fragilenitrosamine, nitrosaminenpyr, npyrnmor, nmorresponses, responsesndma, ndmanmea, nmeanpip, npipndpa, ndpandba, ndbandea, ndealosartan, losartandrug, drugacquisition, acquisitionmin
Application Note Pharma/Biopharma Determination of Nitrosamine Impurities Using the Agilent 6475 Triple Quadrupole LC/MS System Authors Linfeng Wu and Lee Bertram Agilent Technologies, Inc. Santa Clara, CA, U.S. Shan-An Chan Agilent Technologies, Inc. Taiwan Abstract Nitrosamine impurities are by-products that…
Key words
nitrosamine, nitrosaminenmor, nmorresponses, responsesndma, ndmanmea, nmeanpip, npipnpyr, npyrndpa, ndpandba, ndbandea, ndeacounts, countsconcentration, concentrationlosartan, losartanblocker, blockerdrug
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike